Synopsis
Synopsis
0
VMF
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole
2. Ds 103-282
3. Sirdalud
4. Tizanidine
5. Tizanidine Monohydrochloride
6. Zanaflex
1. Tizanidine Hcl
2. 64461-82-1
3. Zanaflex
4. Tizanidine (hydrochloride)
5. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine Hydrochloride
6. Ds 103-282
7. An021
8. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)benzo[c][1,2,5]thiadiazol-4-amine Hydrochloride
9. B53e3nmy5c
10. Tizanidine (as Hydrochloride)
11. 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole Monohydrochloride
12. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine;hydrochloride
13. Ds-103-282
14. 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole Hydrochloride
15. An-021
16. 64461-82-1 (hcl)
17. 2,1,3-benzothiadiazol-4-amine, 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-, Monohydrochloride
18. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazole-4-amine Hydrochloride
19. Smr000499584
20. Unii-b53e3nmy5c
21. Sr-01000765392
22. Tizanidine * Hcl
23. Zanaflex (tn)
24. Mfcd00798231
25. Tizanidine Hydrochloride [usan:usp:jan]
26. 5-iodoisoquinolin-8-ol
27. Schembl41199
28. Mls001076686
29. Mls001306412
30. Mls001333593
31. Chebi:9609
32. Tizanidine Hydrochloride- Bio-x
33. Chembl1200329
34. Dtxsid9046990
35. Ds-103282 Ch
36. Hy-b0194a
37. An-021a
38. Nvd-422
39. Amy18121
40. Bcp28540
41. Tox21_501114
42. S1437
43. Tizanidine Hydrochloride [mi]
44. Tizanidine Hydrochloride (jp17/usp)
45. Tizanidine Hydrochloride [jan]
46. Akos005267234
47. Brn0618691
48. Ccg-220602
49. Ccg-222418
50. Ks-1120
51. Lp01114
52. Nc00654
53. Tizanidine Hydrochloride [usan]
54. Tizanidine Hydrochloride [mart.]
55. Tizanidine Hydrochloride [vandf]
56. Ncgc00261799-01
57. Tizanidine Hydrochloride [who-dd]
58. Ac-22546
59. Bt164478
60. Db-011661
61. Ds-103282
62. Ds103-282
63. Ft-0656022
64. Sw199068-2
65. T2527
66. En300-49853
67. Tizanidine Hydrochloride [orange Book]
68. D00776
69. D70434
70. Tizanidine Hydrochloride [ep Monograph]
71. Tizanidine Hydrochloride [usp Impurity]
72. Tizanidine Hydrochloride [usp Monograph]
73. Tizanidine Hydrochloride, >=98% (hplc), Powder
74. Sr-01000765392-4
75. Q27274381
76. Tizanidine Hydrochloride 100 Microg/ml In Acetonitrile
77. 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazolehydrochloride
78. Tizanidine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
79. (5-chloro-2,1,3-benzothiadiazol-4-yl)-(4,5-dihydro-1h-imidazol-2-yl)azanium;chloride
80. 5-(chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine Hydrochloride
81. 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole Monohydrochloride.
82. 5-chloro-4-[(4,5-dihydro-1h-imidazol-2-yl)amino]-2,1,3-benzothiadiazole Hydrochloride
83. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3benzothiadiazole-4-amine Hydrochloride
84. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)benzo[c][1,2,5]thiadiazol-4-aminehydrochloride
85. Tizanidine Hydrochloride, 500 Mug/ml In Methanol, Certified Reference Material
86. Tizanidine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 290.17 g/mol |
---|---|
Molecular Formula | C9H9Cl2N5S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 288.9955719 g/mol |
Monoisotopic Mass | 288.9955719 g/mol |
Topological Polar Surface Area | 90.4 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 300 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Tizanidine hydrochloride |
PubMed Health | Tizanidine (By mouth) |
Drug Classes | Skeletal Muscle Relaxant, Centrally Acting |
Drug Label | Zanaflex (tizanidine hydrochloride) is a centrally acting 2-adrenergic agonist. Tizanidine HCl (tizanidine) is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor. Tizanidine is slightly soluble in... |
Active Ingredient | Tizanidine hydrochloride |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 4mg base; eq 2mg base; eq 6mg base |
Market Status | Prescription |
Company | Corepharma; Mylan Pharms; Teva; Apotex; Sun Pharm Inds; Prosam Labs; Sandoz; Dr Reddys Labs; Mylan; Unichem Labs |
2 of 4 | |
---|---|
Drug Name | Zanaflex |
Drug Label | Zanaflex (tizanidine hydrochloride) is a centrally acting 2-adrenergic agonist. Tizanidine HCl (tizanidine) is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor. Tizanidine is slightly soluble in... |
Active Ingredient | Tizanidine hydrochloride |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 4mg base; eq 2mg base; eq 6mg base |
Market Status | Prescription |
Company | Acorda |
3 of 4 | |
---|---|
Drug Name | Tizanidine hydrochloride |
PubMed Health | Tizanidine (By mouth) |
Drug Classes | Skeletal Muscle Relaxant, Centrally Acting |
Drug Label | Zanaflex (tizanidine hydrochloride) is a centrally acting 2-adrenergic agonist. Tizanidine HCl (tizanidine) is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor. Tizanidine is slightly soluble in... |
Active Ingredient | Tizanidine hydrochloride |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 4mg base; eq 2mg base; eq 6mg base |
Market Status | Prescription |
Company | Corepharma; Mylan Pharms; Teva; Apotex; Sun Pharm Inds; Prosam Labs; Sandoz; Dr Reddys Labs; Mylan; Unichem Labs |
4 of 4 | |
---|---|
Drug Name | Zanaflex |
Drug Label | Zanaflex (tizanidine hydrochloride) is a centrally acting 2-adrenergic agonist. Tizanidine HCl (tizanidine) is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor. Tizanidine is slightly soluble in... |
Active Ingredient | Tizanidine hydrochloride |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 4mg base; eq 2mg base; eq 6mg base |
Market Status | Prescription |
Company | Acorda |
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Adrenergic alpha-2 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?